The valuation of the global inhalation anesthesia market was USD 1.46 billion in 2022, and it is projected to grow at a CAGR of 9.04% from 2023 to 2030. The growth of the market can be attributed to the rise in surgical procedures and the demand for shorter hospital stays. Inhalation anesthesia offers improved patient outcomes when compared to the intravenous route. Delivering anesthetic agents through the respiratory tract allows for controlled and effective sedation, proving to be cost-effective and safe. The advantages of the inhalation route over the intravenous route serve as significant growth drivers for the market. Inhalation anesthesia is especially beneficial for patients requiring ventilation for more than 24 hours, enabling easy health monitoring. Consequently, the superior patient benefits associated with inhalation anesthesia, as opposed to the intravenous version, are anticipated to propel revenue growth throughout the forecast period.
Download Free Sample Report- https://www.marketdigits.com/request/sample/736
According to data from the NCBI, approximately 310 million major procedures are conducted annually, with 40–50 million occurring in the United States and 20 million in Europe. The post-COVID-19 scenario has led to a surge in elective procedures, consequently driving the demand for inhalation anaesthetics. During the COVID-19 epidemic, the Centres for Medicare and Medicaid Services encouraged hospitals to minimize, postpone, or cancel elective surgeries in 2020, resulting in a 48% decline in surgical procedures in the U.S. In the context of general anesthesia, inhaled anaesthetics are commonly utilized. The National Institutes of Health (NIH) state that over 60,000 individuals undergo surgery while under general anesthesia. Vital life-saving procedures like brain surgery, open heart surgery, or organ transplantation would not be feasible without general anesthesia.
Recent Development in Inhalation Anesthesia Market
Manufacturers have been developing sophisticated anesthesia machines that provide precise control over the concentration of inhaled anesthetics, ensuring patient safety and optimal anesthetic depth during surgical procedures.
Get a discount on report- https://www.marketdigits.com/request/discount/736
Major Classifications are as follows:
Drug Outlook (Revenue, USD Million, 2023 - 2030)
Application Outlook (Revenue, USD Million, 2023 - 2030)
End-Use Outlook (Revenue, USD Million, 2023 - 2030)
• Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Million, 2023 - 2030)
• North America
• Asia Pacific
o South Korea
• Latin America
• Middle East & Africa
o South Africa
o Saudi Arabia
• Halocarbon Products Corporation
• AbbVie Inc.
• Lunan Pharmaceutical Group
• Piramal Enterprises Ltd.
• Sandoz International GmbH
• Fresenius Kabi AG
Request for enquiry before buying- https://www.marketdigits.com/request/enquiry-before-buying/736
Key Questions Addressed by the Report
• What are the growth opportunities in the Inhalation Anesthesia Market?
• What are the major raw materials used for manufacturing Inhalation Anesthesia Market?
• What are the key factors affecting market dynamics?
• What are some of the significant challenges and restraints that the industry faces?
• Which are the key players operating in the market, and what initiatives have they undertaken over the past few years
Inhalation Anesthesia Market Frequently Asked Questions (FAQs):
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
1248 CarMia Way Richmond,
VA 23235, United States.
Phone: +1 510-730-3200
Email: [email protected]